[go: up one dir, main page]

NO20043947L - Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2 - Google Patents

Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2

Info

Publication number
NO20043947L
NO20043947L NO20043947A NO20043947A NO20043947L NO 20043947 L NO20043947 L NO 20043947L NO 20043947 A NO20043947 A NO 20043947A NO 20043947 A NO20043947 A NO 20043947A NO 20043947 L NO20043947 L NO 20043947L
Authority
NO
Norway
Prior art keywords
cyclooxygenase
alpha
combinations
selective inhibitor
delta ligand
Prior art date
Application number
NO20043947A
Other languages
English (en)
Norwegian (no)
Inventor
Jr Charles Price Taylor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20043947L publication Critical patent/NO20043947L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20043947A 2002-02-22 2004-09-21 Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2 NO20043947L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35929502P 2002-02-22 2002-02-22
US40436502P 2002-08-19 2002-08-19
PCT/IB2003/000534 WO2003070237A1 (en) 2002-02-22 2003-02-12 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2

Publications (1)

Publication Number Publication Date
NO20043947L true NO20043947L (no) 2004-09-21

Family

ID=27760521

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043947A NO20043947L (no) 2002-02-22 2004-09-21 Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2

Country Status (21)

Country Link
US (1) US20030199567A1 (es)
EP (1) EP1480639A1 (es)
JP (1) JP2005523281A (es)
KR (1) KR20040085216A (es)
CN (1) CN1635887A (es)
AR (1) AR038531A1 (es)
AU (1) AU2003246864A1 (es)
BR (1) BR0307906A (es)
CA (1) CA2476438A1 (es)
CO (1) CO5611109A2 (es)
HN (1) HN2003000071A (es)
IL (1) IL162932A0 (es)
MX (1) MXPA04008175A (es)
NO (1) NO20043947L (es)
PA (1) PA8567201A1 (es)
PE (1) PE20031052A1 (es)
PL (1) PL372210A1 (es)
RU (1) RU2286151C2 (es)
TW (1) TW200303214A (es)
UY (1) UY27675A1 (es)
WO (1) WO2003070237A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2196201A3 (en) * 2002-12-13 2010-12-08 Warner-Lambert Company LLC Combination of an alpha-2-delta ligand with a pdev inhibitor or a muscarinic antagonist to treat lower urinary tract symptoms
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
PL378583A1 (pl) * 2003-03-21 2006-05-02 Dynogen Pharmaceuticals, Inc. Sposoby leczenia zaburzeń dolnych dróg układu moczowego z zastosowaniem modulatorów mięśni gładkich i modulatorów podjednostki Ó2Ű kanałów wapniowych
US20060264509A1 (en) * 2003-03-21 2006-11-23 Fraser Matthew O Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulators
US7169812B2 (en) 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
ATE449633T1 (de) * 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
GB0322140D0 (en) * 2003-09-22 2003-10-22 Pfizer Ltd Combinations
WO2005041976A2 (en) * 2003-10-23 2005-05-12 Medtronic, Inc. Injectable gabapentin compositions
CL2007001006A1 (es) * 2006-04-11 2008-07-11 Novartis Ag Compuestos derivados de piperidina u 8-aza-biciclo[3.2.1]octano sustituidos; formulacion farmaceutica; producto; y uso para el tratamiento o prevencion de enfermedades tales como diabetes mellitus no insulino dependiente, artritis, obesidad, dislipid
BRPI0718874A2 (pt) * 2006-12-22 2015-06-23 Novartis Ag Compostos orgânicos
EP2286224A4 (en) * 2008-05-05 2012-04-25 Univ Winthrop Hospital METHOD FOR IMPROVING THE CARDIOVASCULAR RISK PROFILE OF COX-INHIBITORS
TR201904388T4 (tr) * 2008-09-05 2019-05-21 Gruenenthal Gmbh Pregabalin veya gabapentin ve 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolün farmasötik kombinasyonu.
KR102631399B1 (ko) * 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
KR20230118081A (ko) * 2020-10-28 2023-08-10 트루모 파마슈티칼스, 인크. 수불용성 cox-2 억제제의 수성 제형

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234929A (en) * 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5420270A (en) * 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5352638A (en) * 1994-02-22 1994-10-04 Corning Incorporated Nickel aluminosilicate glass-ceramics
DK0804182T3 (da) * 1994-07-27 2002-09-09 Warner Lambert Co Anvendelse af gabapentin ved behandling af angst og panik
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
BR9812162A (pt) * 1997-09-08 2000-07-18 Warner Lambert Co Composições analgésicas compreendendo compostos antiepiléticos e métodos para o uso das mesmas
NZ503980A (en) * 1997-12-16 2002-09-27 Warner Lambert Co 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders
AU3216600A (en) * 1999-03-10 2000-09-28 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
GB9927844D0 (en) * 1999-11-26 2000-01-26 Glaxo Group Ltd Chemical compounds
HRP20010582A2 (en) * 1999-12-08 2002-08-31 Pharmacia Corp Valdecoxib compositions

Also Published As

Publication number Publication date
TW200303214A (en) 2003-09-01
EP1480639A1 (en) 2004-12-01
RU2004125609A (ru) 2006-01-27
BR0307906A (pt) 2004-12-21
US20030199567A1 (en) 2003-10-23
UY27675A1 (es) 2003-09-30
CN1635887A (zh) 2005-07-06
AU2003246864A1 (en) 2003-09-09
PE20031052A1 (es) 2003-12-24
PL372210A1 (en) 2005-07-11
JP2005523281A (ja) 2005-08-04
RU2286151C2 (ru) 2006-10-27
KR20040085216A (ko) 2004-10-07
PA8567201A1 (es) 2003-11-12
CA2476438A1 (en) 2003-08-28
WO2003070237A1 (en) 2003-08-28
CO5611109A2 (es) 2006-02-28
HN2003000071A (es) 2003-11-24
IL162932A0 (en) 2005-11-20
AR038531A1 (es) 2005-01-19
MXPA04008175A (es) 2004-11-26

Similar Documents

Publication Publication Date Title
PL367337A1 (pl) Przenikająca przez skórę kompozycja selektywnego inhibitora cyklooksygenazy-2
EP1667683A4 (en) QUINOLINE POTASSIUM CHANNEL INHIBITORS
DE60319430D1 (de) R- und fgfr-inhibitoren
NO20043947L (no) Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2
IS7434A (is) N-amínóasetýl-pýrrólídín-2-karbónítríl og notkun þeirra sem DDP-IV tálma
DK1505963T3 (da) Hepatitis C-inhibitorer
DE60302874D1 (de) Intermittierendes aerosolabgabeventil
DE502004002000D1 (de) Befestigungselement
DE602004018837D1 (de) Ptidase-iv-inhibitoren
EP1499336A4 (en) PROTEASE INHIBITORS
EP1667979A4 (en) ISOCHINOLINE AS KALIUM CHANNEL INHIBITORS
DK1558262T3 (da) Vandoplöselige meloxicam-granulater
IS7575A (is) Própíónsýruafleiður og notkun þeirra sem HPPAR virkjar
PL374279A1 (en) Nitrooxyderivatives of cyclooxygenase-2 inhibitors
DE60307008D1 (de) Erweiterbare Rohrverbindung
DK1501804T3 (da) Isoquinolinderivat MAO-B-inhibitorer
FR2836186B1 (fr) Ventilateur a flux axial
DE50305617D1 (de) Befestigungselement
DE60312074D1 (de) Uhr
PL373523A1 (en) Indol-2-ones as selective inhibitors of cyclooxygenase-2
DE10300447A8 (de) Befestigungselement
IS8109A (is) Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A
IS7963A (is) Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
DE502004006926D1 (de) Fügevorrichtung
FR2843451B1 (fr) Fronde du type lance-pierres